[1] NA R,LIU F,ZHANG P,et al.Evaluation of reportedprostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men[J].Prostate,2013,73(15):1623-1635.
[2] COBBOLD J F,PATEL D,FITZPATRICK J A,et al.Accuracy and reliability of microbubble ultrasound measurements for the non-invasive assessment of hepatic fibrosis in chronic hepatitis C[J].Hepatol Res,2012,42(5):515-522.
[3] FERDINAND F,ANDREA K,ETHAN J,et al.Detection of prostate cancer with a microbubble ultrasound contrast agent[J].Lancet,2001,357(9271):1849-1850.
[4] YANG S L,TANG K Q,BAI W K,et al.Combined low-frequency ultrasound and microbubble contrast agent for the treatment of benign prostatic hyperplasia[J].J Endourol,2013,27(8):1020-1026.
[5] TAKALKAR A M,KLIBANOV A L,RYCHAK J J,et al.Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow[J].J Control Release,2004,96(3):473-482.
[6] SHARIFI N.Steroid receptors aplenty in prostate cancer[J].N Engl J Med,2014,70(10):970-971.
[7] 刘凡.原发性肝癌靶向超声造影剂的制备及体外实验研究[D].广州:南方医科大学,2008.
[8] 齐金蕾,王黎君,周脉耕,等.1990-2013年中国男性前列腺癌疾病负担分析[J].中华流行病学杂志,2016,37(6):778-782.
[9] 潘玉琢,郭丽荣,梁爽,等.前列腺组织STEAP表达与H2O2水平的关系[J].中国病理生理杂志,2008,24(2):354-356.
[10] ABOU-ELKACEM L,BACHAWAL S V,WILLMANN J K.Ultrasound molecular imaging:Moving toward clinical translation[J].Eur J Radiol,2015,84(9):1685-1693. |